Published Guidance, NICE advice and quality standards

Skip to filtersSkip to results

Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 751 to 775 of 1856

TitleReference numberPublishedLast updated
Pneumonia (community-acquired): antimicrobial prescribingNG138
Pneumonia (hospital-acquired): antimicrobial prescribingNG139
Attention deficit hyperactivity disorder: diagnosis and managementNG87
Implant insertion for prominent earsIPG660
Benralizumab for treating severe eosinophilic asthmaTA565
Risankizumab for treating moderate to severe plaque psoriasisTA596
Patisiran for treating hereditary transthyretin amyloidosisHST10
Endovascular insertion of an intrasaccular wire-mesh blood-flow disruption device for intracranial aneurysmsIPG658
Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancerIPG659
Brentuximab vedotin for untreated advanced Hodgkin lymphoma (terminated appraisal)TA594
Dacomitinib for untreated EGFR mutation-positive non-small-cell lung cancerTA595
Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolismNG89
Alcohol interventions in secondary and further educationNG135
PICO negative pressure wound dressings for closed surgical incisionsMTG43
Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitisTA590
Letermovir for preventing cytomegalovirus disease after a stem cell transplantTA591
Chronic obstructive pulmonary disease in over 16s: diagnosis and managementNG115
End of life care for infants, children and young people with life-limiting conditions: planning and managementNG61
Transurethral laser ablation for recurrent non-muscle-invasive bladder cancerIPG656
Ultrasound-guided high-intensity transcutaneous focused ultrasound for symptomatic uterine fibroidsIPG657
Nusinersen for treating spinal muscular atrophyTA588
Blinatumomab for treating acute lymphoblastic leukaemia in remission with minimal residual disease activityTA589
Motor neurone disease: assessment and managementNG42
Therapeutic monitoring of TNF-alpha inhibitors in rheumatoid arthritisDG36
Bisphosphonates for treating osteoporosisTA464

Results per page

  1. 10
  2. 25
  3. 50
  4. All